Free Trial
→ Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (From Brownstone Research) (Ad) Free SAIC Stock Alerts

Science Applications International (SAIC) Financials

$111.85 +0.36 (+0.32%)
As of 04:00 PM Eastern
Compare
Annual Income Statements for Science Applications International

Annual Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 141 117 143 179 137 226 209 277 300 477 362
Consolidated Net Income / (Loss)		 141 117 143 179 137 229 211 279 303 477 362
Net Income / (Loss) Continuing Operations		 141 117 143 179 137 229 211 279 303 477 362
Total Pre-Tax Income 		223 183 212 214 170 286 271 358 375 620 428
Total Operating Income		 240 227 263 256 220 370 390 462 501 741 563
Total Gross Profit		 335 411 439 411 464 706 792 859 888 872 892
Total Revenue		 3,885 4,315 4,442 4,454 4,659 6,379 7,056 7,394 7,704 7,444 7,479
Operating Revenue		 3,885 4,315 4,442 4,454 4,659 6,379 7,056 7,394 7,704 7,444 7,479
Total Cost of Revenue		 3,550 3,904 4,003 4,043 4,195 5,673 6,264 6,535 6,816 6,572 6,587
Operating Cost of Revenue		 3,550 3,904 4,003 4,043 4,195 5,673 6,264 6,535 6,816 6,572 6,587
Total Operating Expenses		 95 184 176 155 244 336 402 397 387 131 329
Selling, General & Admin Expense		 95 184 166 155 158 288 352 344 374 373 339
Other Operating Expenses / (Income)		 - - - - 0.00 0.00 -4.00 -1.00 13 -2.00 -10
Other Special Charges / (Income)		 - - - - - - - -2.00 0.00 -240 0.00
Total Other Income / (Expense), net		 -17 -44 -51 -42 -50 -84 -119 -104 -126 -121 -135
Interest Expense		 17 44 52 44 53 90 122 105 118 120 126
Other Income / (Expense), net		 0.00 0.00 1.00 2.00 3.00 6.00 3.00 1.00 -8.00 -1.00 -9.00
Income Tax Expense		 82 66 69 35 33 57 60 79 72 143 66
Net Income / (Loss) Attributable to Noncontrolling Interest		 - - 0.00 0.00 0.00 3.00 2.00 2.00 3.00 0.00 0.00
Basic Earnings per Share		 $3.01 $2.55 $3.21 $4.13 $3.16 $3.87 $3.60 $4.81 $5.42 $8.98 $7.23
Weighted Average Basic Shares Outstanding		 46.90M 45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M
Diluted Earnings per Share		 $2.91 $2.47 $3.12 $4.02 $3.11 $3.83 $3.56 $4.77 $5.38 $8.88 $7.17
Weighted Average Diluted Shares Outstanding		 46.90M 45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M
Weighted Average Basic & Diluted Shares Outstanding		 46.90M 45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M
Cash Dividends to Common per Share		 $1.28 $1.21 $1.24 $1.24 $1.24 $1.48 $1.48 $1.48 $1.48 $1.48 $1.48

Quarterly Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2022 2/3/2023 5/5/2023 8/4/2023 11/3/2023 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025
Net Income / (Loss) Attributable to Common Shareholders		 80 74 98 247 93 39 77 81 106 98 68
Consolidated Net Income / (Loss)		 80 75 98 247 93 39 77 81 106 98 68
Net Income / (Loss) Continuing Operations		 80 75 98 247 93 39 77 81 106 98 68
Total Pre-Tax Income 		100 85 123 335 114 48 95 100 126 107 86
Total Operating Income		 133 118 157 362 143 79 131 134 160 138 121
Total Gross Profit		 221 222 235 216 229 192 213 210 237 232 209
Total Revenue		 1,909 1,968 2,028 1,784 1,895 1,737 1,847 1,818 1,976 1,838 1,877
Operating Revenue		 1,909 1,968 2,028 1,784 1,895 1,737 1,847 1,818 1,976 1,838 1,877
Total Cost of Revenue		 1,688 1,746 1,793 1,568 1,666 1,545 1,634 1,608 1,739 1,606 1,668
Operating Cost of Revenue		 1,688 1,746 1,793 1,568 1,666 1,545 1,634 1,608 1,739 1,606 1,668
Total Operating Expenses		 88 104 78 -146 86 113 82 76 77 94 88
Selling, General & Admin Expense		 87 102 84 88 87 114 85 77 83 94 89
Other Operating Expenses / (Income)		 0.00 13 0.00 0.00 -1.00 -1.00 -3.00 -1.00 -6.00 - -1.00
Total Other Income / (Expense), net		 -33 -33 -34 -27 -29 -31 -36 -34 -34 -31 -35
Interest Expense		 30 31 32 29 27 32 34 31 32 29 30
Other Income / (Expense), net		 -3.00 -2.00 -2.00 2.00 -2.00 1.00 -2.00 -3.00 -2.00 -2.00 -5.00
Income Tax Expense		 20 10 25 88 21 9.00 18 19 20 9.00 18
Basic Earnings per Share		 $1.45 $1.36 $1.80 $4.60 $1.79 $0.79 $1.49 $1.59 $2.15 $2.00 $1.43
Weighted Average Basic Shares Outstanding		 54.63M 54.20M 53.68M 52.94M 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M
Diluted Earnings per Share		 $1.45 $1.34 $1.79 $4.56 $1.76 $0.77 $1.48 $1.58 $2.13 $1.98 $1.42
Weighted Average Diluted Shares Outstanding		 54.63M 54.20M 53.68M 52.94M 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M
Weighted Average Basic & Diluted Shares Outstanding		 54.63M 54.20M 53.68M 52.94M 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M
Cash Dividends to Common per Share		 $0.37 - $0.37 $0.37 $0.37 - $0.37 $0.37 $0.37 - $0.37

Annual Cash Flow Statements for Science Applications International

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025
Net Change in Cash & Equivalents		 47 -92 9.00 -66 94 -44 -12 -75 3.00 -15 -39
Net Cash From Operating Activities		 277 226 273 217 184 458 755 518 532 396 494
Net Cash From Continuing Operating Activities		 277 226 273 217 184 458 755 518 532 396 494
Net Income / (Loss) Continuing Operations		 141 117 143 179 137 229 211 279 303 477 362
Consolidated Net Income / (Loss)		 141 117 143 179 137 229 211 279 303 477 362
Depreciation Expense		 21 62 53 46 47 131 179 165 157 142 140
Non-Cash Adjustments To Reconcile Net Income		 32 24 16 27 85 42 54 62 47 -185 46
Changes in Operating Assets and Liabilities, net		 83 23 61 -35 -87 49 305 38 25 -38 -54
Net Cash From Investing Activities		 -22 -784 -17 -22 -1,028 -47 -1,231 -292 -36 314 -35
Net Cash From Continuing Investing Activities		 -22 -784 -17 -22 -1,028 -47 -1,231 -292 -36 314 -35
Purchase of Property, Plant & Equipment		 -22 -20 -15 -22 -28 -21 -46 -36 -25 -27 -36
Acquisitions		 0.00 -764 0.00 0.00 -1,001 0.00 -1,202 -255 0.00 -8.00 0.00
Purchase of Investments		 - - - 0.00 0.00 -24 -6.00 -9.00 -7.00 -8.00 -14
Divestitures		 - - - - 0.00 0.00 17 8.00 0.00 356 10
Sale and/or Maturity of Investments		 - - - 0.00 0.00 3.00 9.00 6.00 4.00 6.00 12
Other Investing Activities, net		 0.00 - -2.00 0.00 1.00 -5.00 -3.00 -6.00 -8.00 -5.00 -7.00
Net Cash From Financing Activities		 -208 466 -247 -261 938 -455 464 -301 -493 -725 -498
Net Cash From Continuing Financing Activities		 -208 466 -247 -261 938 -455 464 -301 -493 -725 -498
Repayment of Debt		 -13 -89 -238 -50 -805 -274 -426 -119 -999 -441 -1,384
Repurchase of Common Equity		 -149 -69 -180 -186 -71 -197 -34 -226 -267 -382 -558
Payment of Dividends		 -52 -55 -54 -54 -52 -94 -89 -88 -83 -79 -75
Issuance of Debt		 0.00 670 209 25 1,859 100 1,000 116 840 160 1,499
Issuance of Common Equity		 3.00 4.00 5.00 6.00 7.00 10 13 16 16 17 20
Cash Interest Paid		 17 36 48 41 44 86 96 98 111 125 121
Cash Income Taxes Paid		 49 53 46 31 24 32 39 7.00 70 165 66

Quarterly Cash Flow Statements for Science Applications International

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2022 2/3/2023 5/5/2023 8/4/2023 11/3/2023 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025
Net Change in Cash & Equivalents		 -46 56 313 -70 -41 -217 -45 -2.00 -2.00 10 -9.00
Net Cash From Operating Activities		 128 145 82 150 101 63 98 138 143 115 100
Net Cash From Continuing Operating Activities		 128 145 84 148 101 63 98 136 143 115 100
Net Income / (Loss) Continuing Operations		 80 75 98 247 93 39 77 81 106 98 68
Consolidated Net Income / (Loss)		 80 75 98 247 93 39 77 81 106 98 68
Depreciation Expense		 37 39 36 36 34 36 35 34 35 36 36
Non-Cash Adjustments To Reconcile Net Income		 12 12 6.00 -229 14 24 12 8.00 7.00 17 15
Changes in Operating Assets and Liabilities, net		 3.00 15 -56 94 -40 -36 -26 13 -5.00 -36 -19
Net Cash From Investing Activities		 -6.00 -13 336 -2.00 -10 -10 -7.00 -9.00 1.00 -20 -15
Net Cash From Continuing Investing Activities		 -6.00 -13 336 -2.00 -10 -10 -7.00 -9.00 1.00 -20 -15
Purchase of Property, Plant & Equipment		 -6.00 -7.00 -6.00 -6.00 -4.00 -11 -6.00 -6.00 -9.00 -15 -8.00
Purchase of Investments		 -1.00 -2.00 -3.00 -2.00 -1.00 -2.00 -4.00 -4.00 -3.00 -3.00 -4.00
Sale and/or Maturity of Investments		 1.00 1.00 1.00 3.00 1.00 1.00 4.00 2.00 4.00 2.00 3.00
Other Investing Activities, net		 - -5.00 -3.00 - -7.00 5.00 -1.00 -1.00 -1.00 -4.00 -6.00
Net Cash From Financing Activities		 -168 -76 -105 -218 -132 -270 -136 -131 -146 -85 -94
Net Cash From Continuing Financing Activities		 -168 -76 -105 -218 -132 -270 -136 -131 -146 -85 -94
Repayment of Debt		 -206 -213 -160 -100 -15 -166 -310 -296 -450 -328 -689
Repurchase of Common Equity		 -60 -59 -88 -102 -103 -89 -103 -201 -121 -133 -142
Payment of Dividends		 -21 -18 -21 -20 -19 -19 -20 -19 -18 -18 -19
Issuance of Debt		 115 210 160 - - - 293 380 441 385 750
Issuance of Common Equity		 4.00 4.00 4.00 4.00 5.00 4.00 4.00 5.00 5.00 6.00 6.00

Annual Balance Sheets for Science Applications International

This table presents Science Applications International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025
Total Assets		 1,389 2,122 2,042 784 4,563 4,711 5,723 5,746 5,543 5,314 5,246
Total Current Assets		 942 952 901 753 1,433 1,430 1,289 1,263 1,197 1,131 1,154
Cash & Equivalents		 301 195 210 - 237 188 171 106 109 94 56
Accounts Receivable		 544 635 539 673 1,050 1,099 962 1,015 936 914 1,000
Prepaid Expenses		 20 21 27 - 47 40 56 57 58 93 98
Plant, Property, & Equipment, net		 59 71 60 0.00 103 91 108 100 92 91 104
Total Noncurrent Assets		 388 1,099 1,081 31 3,027 3,190 4,326 4,383 4,254 4,092 3,988
Goodwill		 379 860 863 - 2,120 2,139 2,787 2,913 2,911 2,851 2,851
Intangible Assets		 2.00 224 200 - 803 711 1,138 1,132 1,009 894 779
Other Noncurrent Operating Assets		 7.00 15 18 31 104 340 401 338 320 347 358
Total Liabilities & Shareholders' Equity		 1,389 2,122 2,042 491 4,563 4,711 5,723 5,746 5,543 5,314 5,246
Total Liabilities		 1,044 1,742 1,693 165 3,064 3,284 4,171 4,117 3,839 3,529 3,669
Total Current Liabilities		 552 688 623 94 897 1,128 1,275 1,352 1,126 1,158 1,396
Short-Term Debt		 32 57 25 - 24 70 68 148 31 77 313
Accounts Payable		 315 351 329 - 455 527 517 612 624 567 631
Accrued Expenses		 205 280 269 94 297 405 494 365 266 265 113
Current Employee Benefit Liabilities		 - - - - 121 126 196 227 205 249 339
Total Noncurrent Liabilities		 492 1,054 1,070 71 2,167 2,156 2,896 2,765 2,713 2,371 2,273
Long-Term Debt		 454 1,013 1,022 - 2,065 1,851 2,447 2,370 2,343 2,022 1,907
Noncurrent Deferred & Payable Income Tax Liabilities		 19 8.00 10 24 - - 2.00 43 0.00 28 24
Other Noncurrent Operating Liabilities		 19 33 38 47 102 305 447 352 370 321 342
Commitments & Contingencies		 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 345 380 349 326 1,499 1,427 1,552 1,629 1,704 1,785 1,577
Total Preferred & Common Equity		 345 380 349 326 1,485 1,417 1,542 1,619 1,694 1,785 1,577
Total Common Equity		 345 380 349 326 1,485 1,417 1,542 1,619 1,694 1,785 1,577
Common Stock		 234 215 91 - 1,132 983 1,004 838 637 337 0.00
Retained Earnings		 116 174 260 326 367 506 627 818 1,035 1,432 1,565
Accumulated Other Comprehensive Income / (Loss)		 -5.00 -9.00 -2.00 - -14 -72 -89 -37 22 16 12

Quarterly Balance Sheets for Science Applications International

This table presents Science Applications International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 10/29/2021 4/29/2022 7/29/2022 10/28/2022 5/5/2023 8/4/2023 11/3/2023 5/3/2024 8/2/2024 11/1/2024 5/2/2025
Total Assets		 5,916 5,716 5,654 5,628 5,957 5,672 5,658 5,250 5,250 5,275 5,211
Total Current Assets		 1,383 1,291 1,270 1,247 1,675 1,384 1,388 1,091 1,103 1,160 1,148
Cash & Equivalents		 148 56 99 53 422 352 311 49 48 46 47
Accounts Receivable		 1,107 1,104 1,036 1,059 995 958 1,010 934 946 1,022 1,009
Prepaid Expenses		 128 131 135 135 77 74 67 108 109 92 92
Plant, Property, & Equipment, net		 103 97 95 95 91 90 89 93 95 99 102
Total Noncurrent Assets		 4,430 4,328 4,289 4,286 4,191 4,198 4,181 4,066 4,052 4,016 3,961
Goodwill		 2,905 2,911 2,911 2,911 2,851 2,851 2,851 2,851 2,851 2,851 2,851
Intangible Assets		 1,166 1,101 1,069 1,040 980 951 923 865 836 807 750
Other Noncurrent Operating Assets		 359 316 309 335 360 396 407 350 365 358 360
Total Liabilities & Shareholders' Equity		 5,916 5,716 5,654 5,628 5,957 5,672 5,658 5,250 5,250 5,275 5,211
Total Liabilities		 4,271 4,066 4,001 3,932 4,265 3,829 3,830 3,491 3,625 3,663 3,706
Total Current Liabilities		 1,395 1,334 1,190 1,230 1,553 1,212 1,226 1,154 1,292 1,337 1,474
Short-Term Debt		 119 119 0.00 15 46 62 69 90 197 220 405
Accounts Payable		 877 820 853 819 809 820 840 648 639 714 668
Accrued Expenses		 - - - - - - - 129 118 92 113
Current Employee Benefit Liabilities		 399 395 337 396 277 330 317 287 338 311 288
Total Noncurrent Liabilities		 2,876 2,732 2,811 2,702 2,712 2,617 2,604 2,337 2,333 2,326 2,232
Long-Term Debt		 2,433 2,342 2,462 2,358 2,329 2,215 2,194 1,993 1,970 1,939 1,876
Noncurrent Deferred & Payable Income Tax Liabilities		 - 45 7.00 0.00 - - - 29 19 12 22
Other Noncurrent Operating Liabilities		 443 345 342 344 383 402 410 315 344 375 334
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,645 1,650 1,653 1,696 1,692 1,843 1,828 1,759 1,625 1,612 1,505
Total Preferred & Common Equity		 1,635 1,640 1,643 1,686 1,692 1,843 1,828 1,759 1,625 1,612 1,505
Total Common Equity		 1,635 1,640 1,643 1,686 1,692 1,843 1,828 1,759 1,625 1,612 1,505
Common Stock		 896 770 723 679 563 480 395 251 63 0.00 0.00
Retained Earnings		 796 870 923 981 1,113 1,340 1,413 1,489 1,551 1,602 1,494
Accumulated Other Comprehensive Income / (Loss)		 -57 0.00 -3.00 26 16 23 20 19 11 10 11

Annual Metrics And Ratios for Science Applications International

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/30/2015 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -5.73% 11.07% 2.94% 0.27% 4.60% 36.92% 10.61% 4.79% 4.19% -3.37% 0.47%
EBITDA Growth		 33.16% 10.73% 9.69% -4.10% -10.53% 88.97% 12.45% 4.15% 7.97% 35.69% -21.32%
EBIT Growth		 31.15% -5.42% 16.30% -2.27% -13.57% 68.61% 4.52% 17.81% 6.48% 50.10% -25.14%
NOPAT Growth		 29.15% -4.36% 22.23% 20.70% -17.20% 67.10% 2.50% 18.57% 12.43% 40.83% -16.47%
Net Income Growth		 24.78% -17.02% 22.22% 25.17% -23.46% 67.15% -7.86% 32.23% 8.60% 57.43% -24.11%
EPS Growth		 28.19% -15.12% 26.32% 28.85% -22.64% 23.15% -7.05% 33.99% 12.79% 65.06% -19.26%
Operating Cash Flow Growth		 51.37% -18.41% 20.80% -20.51% -15.21% 148.91% 64.85% -31.39% 2.70% -25.56% 24.75%
Free Cash Flow Firm Growth		 172.67% -335.00% 142.49% -21.62% -1,118.33% 124.78% -188.73% 149.74% 121.72% 57.11% -29.89%
Invested Capital Growth		 -15.20% 136.79% -5.50% 1.77% 177.63% -5.70% 23.29% 3.72% -1.78% -4.51% -1.29%
Revenue Q/Q Growth		 0.28% 2.84% -1.18% 2.53% 1.39% 5.77% 2.57% 0.89% 2.47% -3.01% 1.37%
EBITDA Q/Q Growth		 1.95% 3.58% -2.46% 4.11% -16.05% 26.60% 4.71% -4.44% 5.86% -4.23% 8.78%
EBIT Q/Q Growth		 1.27% -2.16% 0.00% 4.45% -19.78% 27.89% 3.97% -4.54% 7.17% -4.64% 11.25%
NOPAT Q/Q Growth		 2.08% -1.41% 0.80% 12.32% -25.38% 34.55% 0.76% -3.76% 10.35% -6.40% 15.06%
Net Income Q/Q Growth		 2.17% -6.40% 2.14% 12.58% -30.46% 43.13% 0.48% -5.74% 11.40% -7.02% 19.47%
EPS Q/Q Growth		 3.19% -5.73% 2.97% 13.24% -31.35% 49.61% 1.14% -5.73% 12.08% -6.03% 20.30%
Operating Cash Flow Q/Q Growth		 -9.48% 5.61% -14.42% 11.28% -25.20% 11.44% -2.08% 10.68% 8.57% -17.15% 11.76%
Free Cash Flow Firm Q/Q Growth		 138.78% -298.44% -16.76% 18.74% -1,033.82% 128.87% -8.19% 13.72% 19.25% -11.35% 12.01%
Invested Capital Q/Q Growth		 -63.82% -4.92% -1.17% -1.71% 167.01% -0.09% 0.83% -0.20% -1.17% 0.26% 0.43%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 8.62% 9.52% 9.88% 9.23% 9.96% 11.07% 11.22% 11.62% 11.53% 11.71% 11.93%
EBITDA Margin		 6.72% 6.70% 7.14% 6.83% 5.84% 8.06% 8.19% 8.14% 8.44% 11.85% 9.28%
Operating Margin		 6.18% 5.26% 5.92% 5.75% 4.72% 5.80% 5.53% 6.25% 6.50% 9.95% 7.53%
EBIT Margin		 6.18% 5.26% 5.94% 5.79% 4.79% 5.89% 5.57% 6.26% 6.40% 9.94% 7.41%
Profit (Net Income) Margin		 3.63% 2.71% 3.22% 4.02% 2.94% 3.59% 2.99% 3.77% 3.93% 6.41% 4.84%
Tax Burden Percent		 63.23% 63.93% 67.45% 83.64% 80.59% 80.07% 77.86% 77.93% 80.80% 76.94% 84.58%
Interest Burden Percent		 92.92% 80.62% 80.30% 82.95% 76.23% 76.06% 68.96% 77.32% 76.06% 83.78% 77.26%
Effective Tax Rate		 36.77% 36.07% 32.55% 16.36% 19.41% 19.93% 22.14% 22.07% 19.20% 23.06% 15.42%
Return on Invested Capital (ROIC)		 26.28% 16.26% 14.54% 17.90% 7.78% 9.10% 8.61% 9.07% 10.11% 14.70% 12.65%
ROIC Less NNEP Spread (ROIC-NNEP)		 21.31% 10.95% 10.52% 13.80% 4.83% 5.35% 4.06% 5.66% 5.75% 10.33% 7.17%
Return on Net Nonoperating Assets (RNNOA)		 12.78% 16.01% 24.70% 35.06% 7.23% 6.55% 5.56% 8.47% 8.07% 12.65% 8.89%
Return on Equity (ROE)		 39.06% 32.28% 39.23% 52.96% 15.01% 15.65% 14.17% 17.54% 18.18% 27.34% 21.53%
Cash Return on Invested Capital (CROIC)		 42.73% -64.97% 20.19% 16.14% -86.30% 14.97% -12.25% 5.42% 11.91% 19.31% 13.95%
Operating Return on Assets (OROA)		 16.93% 12.93% 12.68% 12.54% 6.72% 8.11% 7.53% 8.07% 8.73% 13.63% 10.49%
Return on Assets (ROA)		 9.94% 6.66% 6.87% 8.70% 4.13% 4.94% 4.04% 4.87% 5.37% 8.79% 6.86%
Return on Common Equity (ROCE)		 39.06% 32.28% 39.23% 52.96% 14.89% 15.52% 14.07% 17.43% 18.07% 27.26% 21.53%
Return on Equity Simple (ROE_SIMPLE)		 40.87% 30.79% 40.97% 54.74% 9.23% 16.16% 13.68% 17.23% 17.89% 26.72% 22.96%
Net Operating Profit after Tax (NOPAT)		 152 145 177 214 177 296 304 360 405 570 476
NOPAT Margin		 3.91% 3.36% 3.99% 4.81% 3.81% 4.64% 4.30% 4.87% 5.25% 7.66% 6.37%
Net Nonoperating Expense Percent (NNEP)		 4.96% 5.31% 4.02% 4.09% 2.95% 3.75% 4.55% 3.41% 4.35% 4.36% 5.48%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 9.93% 14.68% 12.54%
Cost of Revenue to Revenue		 91.38% 90.48% 90.12% 90.77% 90.04% 88.93% 88.78% 88.38% 88.47% 88.29% 88.07%
SG&A Expenses to Revenue		 2.45% 4.26% 3.74% 3.48% 3.39% 4.51% 4.99% 4.65% 4.85% 5.01% 4.53%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 2.45% 4.26% 3.96% 3.48% 5.24% 5.27% 5.70% 5.37% 5.02% 1.76% 4.40%
Earnings before Interest and Taxes (EBIT)		 240 227 264 258 223 376 393 463 493 740 554
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 261 289 317 304 272 514 578 602 650 882 694
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.47 4.43 9.21 8.80 1.77 3.33 3.44 2.76 3.27 3.72 3.36
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.49 0.39 0.72 0.65 0.57 0.74 0.75 0.60 0.72 0.89 0.71
Price to Earnings (P/E)		 13.38 14.38 22.47 16.07 19.23 20.89 25.40 16.15 18.49 13.91 14.62
Dividend Yield		 2.71% 3.27% 1.69% 1.84% 2.00% 1.81% 1.62% 1.88% 1.46% 1.16% 1.37%
Earnings Yield		 7.47% 6.95% 4.45% 6.22% 5.20% 4.79% 3.94% 6.19% 5.41% 7.19% 6.84%
Enterprise Value to Invested Capital (EV/IC)		 3.91 2.04 3.42 3.11 1.34 2.05 1.97 1.71 1.97 2.28 1.99
Enterprise Value to Revenue (EV/Rev)		 0.53 0.59 0.91 0.84 0.97 1.01 1.09 0.93 1.02 1.16 1.00
Enterprise Value to EBITDA (EV/EBITDA)		 7.94 8.85 12.78 12.36 16.54 12.58 13.26 11.45 12.03 9.80 10.74
Enterprise Value to EBIT (EV/EBIT)		 8.63 11.27 15.34 14.56 20.18 17.19 19.50 14.89 15.87 11.68 13.46
Enterprise Value to NOPAT (EV/NOPAT)		 13.65 17.62 22.83 17.55 25.38 21.82 25.24 19.15 19.32 15.16 15.66
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.48 11.32 14.84 17.31 24.46 14.11 10.15 13.31 14.70 21.82 15.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 8.40 0.00 16.44 19.45 0.00 13.27 0.00 32.06 16.40 11.54 14.20
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.41 2.82 3.00 3.13 1.39 1.35 1.62 1.55 1.39 1.18 1.41
Long-Term Debt to Equity		 1.32 2.67 2.93 3.01 1.38 1.30 1.58 1.45 1.38 1.13 1.21
Financial Leverage		 0.60 1.46 2.35 2.54 1.50 1.23 1.37 1.50 1.40 1.22 1.24
Leverage Ratio		 3.93 4.84 5.71 6.09 3.63 3.17 3.50 3.61 3.39 3.11 3.14
Compound Leverage Factor		 3.65 3.90 4.59 5.05 2.77 2.41 2.42 2.79 2.58 2.61 2.43
Debt to Total Capital		 58.48% 73.79% 75.00% 75.80% 58.22% 57.38% 61.84% 60.72% 58.21% 54.04% 58.47%
Short-Term Debt to Total Capital		 3.85% 3.93% 1.79% 3.03% 0.67% 2.09% 1.67% 3.57% 0.76% 1.98% 8.24%
Long-Term Debt to Total Capital		 54.63% 69.86% 73.21% 72.76% 57.55% 55.29% 60.17% 57.15% 57.45% 52.06% 50.22%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.39% 0.30% 0.25% 0.24% 0.25% 0.00% 0.00%
Common Equity to Total Capital		 41.52% 26.21% 25.00% 24.20% 41.39% 42.32% 37.91% 39.04% 41.54% 45.96% 41.53%
Debt to EBITDA		 1.86 3.70 3.30 3.37 7.68 3.74 4.35 4.18 3.65 2.38 3.20
Net Debt to EBITDA		 0.71 3.03 2.64 2.89 6.81 3.37 4.06 4.01 3.48 2.27 3.12
Long-Term Debt to EBITDA		 1.74 3.51 3.22 3.23 7.59 3.60 4.23 3.94 3.60 2.29 2.75
Debt to NOPAT		 3.20 7.37 5.90 4.78 11.78 6.48 8.28 6.99 5.86 3.68 4.66
Net Debt to NOPAT		 1.22 6.03 4.72 4.11 10.45 5.85 7.72 6.70 5.60 3.52 4.54
Long-Term Debt to NOPAT		 2.99 6.98 5.76 4.59 11.65 6.25 8.06 6.58 5.79 3.55 4.00
Altman Z-Score		 4.91 3.23 4.08 3.91 1.95 2.71 2.38 2.39 2.83 3.36 3.00
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.77% 0.82% 0.67% 0.63% 0.60% 0.29% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.71 1.38 1.45 1.37 1.60 1.27 1.01 0.93 1.06 0.98 0.83
Quick Ratio		 1.53 1.21 1.20 1.18 1.43 1.14 0.89 0.83 0.93 0.87 0.76
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 247 -580 246 193 -1,967 487 -432 215 477 749 525
Operating Cash Flow to CapEx		 1,259.09% 1,130.00% 1,820.00% 986.36% 657.14% 2,180.95% 1,641.30% 1,438.89% 2,128.00% 1,466.67% 1,372.22%
Free Cash Flow to Firm to Interest Expense		 14.51 -13.18 4.74 4.39 -37.11 5.41 -3.54 2.05 4.04 6.24 4.17
Operating Cash Flow to Interest Expense		 16.29 5.14 5.25 4.93 3.47 5.09 6.19 4.93 4.51 3.30 3.92
Operating Cash Flow Less CapEx to Interest Expense		 15.00 4.68 4.96 4.43 2.94 4.86 5.81 4.59 4.30 3.08 3.63
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.74 2.46 2.13 2.16 1.40 1.38 1.35 1.29 1.36 1.37 1.42
Accounts Receivable Turnover		 6.67 7.32 7.57 7.34 5.40 5.94 6.85 7.48 7.90 8.05 7.82
Inventory Turnover		 56.35 57.84 57.60 58.17 59.08 71.81 77.33 92.04 100.98 0.00 0.00
Fixed Asset Turnover		 65.29 66.38 67.82 73.62 56.82 65.76 70.91 71.10 80.25 81.36 76.71
Accounts Payable Turnover		 10.89 11.72 11.77 11.14 9.85 11.55 12.00 11.58 11.03 11.04 11.00
Days Sales Outstanding (DSO)		 54.73 49.87 48.23 49.70 67.53 61.48 53.31 48.80 46.22 45.36 46.70
Days Inventory Outstanding (DIO)		 6.48 6.31 6.34 6.27 6.18 5.08 4.72 3.97 3.61 0.00 0.00
Days Payable Outstanding (DPO)		 33.52 31.13 31.00 32.77 37.07 31.59 30.42 31.53 33.09 33.07 33.19
Cash Conversion Cycle (CCC)		 27.69 25.04 23.57 23.20 36.64 34.97 27.61 21.23 16.74 12.28 13.51
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 530 1,255 1,186 1,207 3,351 3,160 3,896 4,041 3,969 3,790 3,741
Invested Capital Turnover		 6.73 4.83 3.64 3.72 2.04 1.96 2.00 1.86 1.92 1.92 1.99
Increase / (Decrease) in Invested Capital		 -95 725 -69 21 2,144 -191 736 145 -72 -179 -49
Enterprise Value (EV)		 2,072 2,558 4,050 3,757 4,500 6,464 7,663 6,894 7,822 8,642 7,457
Market Capitalization		 1,887 1,683 3,213 2,877 2,634 4,721 5,309 4,472 5,547 6,637 5,293
Book Value per Share		 $7.55 $8.36 $7.95 $7.65 $34.90 $24.55 $26.48 $28.43 $31.01 $34.29 $32.26
Tangible Book Value per Share		 ($0.79) ($15.48) ($16.27) ($16.72) ($33.80) ($24.83) ($40.93) ($42.61) ($40.75) ($37.65) ($42.00)
Total Capital		 831 1,450 1,396 1,351 3,588 3,348 4,067 4,147 4,078 3,884 3,797
Total Debt		 486 1,070 1,047 1,024 2,089 1,921 2,515 2,518 2,374 2,099 2,220
Total Long-Term Debt		 454 1,013 1,022 983 2,065 1,851 2,447 2,370 2,343 2,022 1,907
Net Debt		 185 875 837 880 1,852 1,733 2,344 2,412 2,265 2,005 2,164
Capital Expenditures (CapEx)		 22 20 15 22 28 21 46 36 25 27 36
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 121 126 93 152 323 184 -89 -47 -7.00 -44 15
Debt-free Net Working Capital (DFNWC)		 422 321 303 296 560 372 82 59 102 50 71
Net Working Capital (NWC)		 390 264 278 255 536 302 14 -89 71 -27 -242
Net Nonoperating Expense (NNE)		 11 28 34 35 40 67 93 81 102 93 114
Net Nonoperating Obligations (NNO)		 185 875 837 880 1,852 1,733 2,344 2,412 2,265 2,005 2,164
Total Depreciation and Amortization (D&A)		 21 62 53 46 49 138 185 139 157 142 140
Debt-free, Cash-free Net Working Capital to Revenue		 3.11% 2.92% 2.09% 3.41% 6.93% 2.88% -1.26% -0.64% -0.09% -0.59% 0.20%
Debt-free Net Working Capital to Revenue		 10.86% 7.44% 6.82% 6.65% 12.02% 5.83% 1.16% 0.80% 1.32% 0.67% 0.95%
Net Working Capital to Revenue		 10.04% 6.12% 6.26% 5.73% 11.50% 4.73% 0.20% -1.20% 0.92% -0.36% -3.24%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($4.36) $2.55 $3.33 $4.13 $3.16 $3.87 $3.60 $4.81 $5.42 $8.98 $7.23
Adjusted Weighted Average Basic Shares Outstanding		 74.13M 44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M
Adjusted Diluted Earnings per Share		 ($4.36) $2.47 $3.22 $4.02 $3.11 $3.83 $3.56 $4.77 $5.38 $8.88 $7.17
Adjusted Weighted Average Diluted Shares Outstanding		 74.13M 44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $4.13 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 74.13M 44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M
Normalized Net Operating Profit after Tax (NOPAT)		 152 145 184 214 247 335 346 402 405 385 476
Normalized NOPAT Margin		 3.91% 3.36% 4.15% 4.81% 5.29% 5.25% 4.90% 5.44% 5.25% 5.18% 6.37%
Pre Tax Income Margin		 5.74% 4.24% 4.77% 4.80% 3.65% 4.48% 3.84% 4.84% 4.87% 8.33% 5.72%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 14.12 5.16 5.08 5.86 4.21 4.18 3.22 4.41 4.18 6.17 4.40
NOPAT to Interest Expense		 8.93 3.30 3.41 4.87 3.35 3.29 2.49 3.43 3.43 4.75 3.78
EBIT Less CapEx to Interest Expense		 12.82 4.70 4.79 5.36 3.68 3.94 2.84 4.07 3.97 5.94 4.11
NOPAT Less CapEx to Interest Expense		 7.63 2.84 3.12 4.37 2.82 3.06 2.11 3.09 3.22 4.53 3.49
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 36.88% 47.01% 37.76% 30.17% 37.96% 41.05% 42.18% 31.54% 27.39% 16.56% 20.72%
Augmented Payout Ratio		 142.55% 105.98% 163.64% 134.08% 89.78% 127.07% 58.29% 112.54% 115.51% 96.65% 174.86%

Quarterly Metrics And Ratios for Science Applications International

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 10/28/2022 2/3/2023 5/5/2023 8/4/2023 11/3/2023 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.58% 10.44% 1.60% -2.57% -0.73% -11.74% -8.93% 1.91% 4.27% 5.81% 1.62%
EBITDA Growth		 10.88% 26.02% 17.18% 142.42% 7.36% -25.16% -14.14% -58.75% 10.29% 48.28% -7.32%
EBIT Growth		 14.04% 39.76% 27.05% 191.20% 8.46% -31.03% -16.77% -64.01% 12.06% 70.00% -10.08%
NOPAT Growth		 15.68% 58.68% 28.47% 174.12% 9.64% -38.35% -15.12% -59.33% 15.38% 96.91% -9.89%
Net Income Growth		 12.68% 70.45% 32.43% 233.78% 16.25% -48.00% -21.43% -67.21% 13.98% 151.28% -11.69%
EPS Growth		 18.85% 76.32% 38.76% 250.77% 21.38% -42.54% -17.32% -65.35% 21.02% 157.14% -4.05%
Operating Cash Flow Growth		 -4.48% 40.78% -30.51% 6.38% -21.09% -56.55% 19.51% -8.00% 41.58% 82.54% 2.04%
Free Cash Flow Firm Growth		 249.86% 321.85% 572.34% 244.72% 152.98% 38.08% -124.12% -74.26% -46.24% -27.88% 195.44%
Invested Capital Growth		 -0.82% -1.78% -12.95% -6.18% -5.88% -4.51% 7.45% -0.64% -1.46% -1.29% -1.42%
Revenue Q/Q Growth		 4.26% 3.09% 3.05% -12.03% 6.22% -8.34% 6.33% -1.57% 8.69% -6.98% 2.12%
EBITDA Q/Q Growth		 -1.21% -4.91% 24.03% 109.42% -56.25% -33.71% 41.38% 0.61% 16.97% -10.88% -11.63%
EBIT Q/Q Growth		 4.00% -10.77% 33.62% 134.84% -61.26% -43.26% 61.25% 1.55% 20.61% -13.92% -14.71%
NOPAT Q/Q Growth		 9.28% -2.15% 20.14% 113.37% -56.29% -44.98% 65.42% 2.22% 24.01% -6.10% -24.30%
Net Income Q/Q Growth		 8.11% -6.25% 30.67% 152.04% -62.35% -58.06% 97.44% 5.19% 30.86% -7.55% -30.61%
EPS Q/Q Growth		 11.54% -7.59% 33.58% 154.75% -61.40% -56.25% 92.21% 6.76% 34.81% -7.04% -28.28%
Operating Cash Flow Q/Q Growth		 -9.22% 13.28% -43.45% 82.93% -32.67% -37.62% 55.56% 40.82% 3.62% -19.58% -13.04%
Free Cash Flow Firm Q/Q Growth		 -6.67% 26.34% 269.12% -20.79% -31.51% -31.04% -164.49% 184.52% 43.05% -7.49% -14.66%
Invested Capital Q/Q Growth		 0.00% -1.17% -11.06% 6.74% 0.32% 0.26% 0.08% -1.29% -0.51% 0.43% -0.05%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 11.58% 11.28% 11.59% 12.11% 12.08% 11.05% 11.53% 11.55% 11.99% 12.62% 11.13%
EBITDA Margin		 8.54% 7.88% 9.42% 22.42% 9.23% 6.68% 8.88% 9.08% 9.77% 9.36% 8.10%
Operating Margin		 6.97% 6.00% 7.74% 20.29% 7.55% 4.55% 7.09% 7.37% 8.10% 7.51% 6.45%
EBIT Margin		 6.81% 5.89% 7.64% 20.40% 7.44% 4.61% 6.98% 7.21% 8.00% 7.40% 6.18%
Profit (Net Income) Margin		 4.19% 3.81% 4.83% 13.85% 4.91% 2.25% 4.17% 4.46% 5.36% 5.33% 3.62%
Tax Burden Percent		 80.00% 88.24% 79.67% 73.73% 81.58% 81.25% 81.05% 81.00% 84.13% 91.59% 79.07%
Interest Burden Percent		 76.92% 73.28% 79.35% 92.03% 80.85% 60.00% 73.64% 76.34% 79.75% 78.68% 74.14%
Effective Tax Rate		 20.00% 11.76% 20.33% 26.27% 18.42% 18.75% 18.95% 19.00% 15.87% 8.41% 20.93%
Return on Invested Capital (ROIC)		 10.39% 10.18% 12.58% 29.56% 12.12% 7.09% 11.40% 11.60% 13.39% 13.66% 10.16%
ROIC Less NNEP Spread (ROIC-NNEP)		 9.27% 8.93% 11.30% 28.63% 11.01% 5.91% 9.90% 10.24% 11.99% 12.30% 8.87%
Return on Net Nonoperating Assets (RNNOA)		 13.11% 12.53% 14.35% 35.11% 13.35% 7.23% 11.10% 11.94% 14.16% 15.25% 11.59%
Return on Equity (ROE)		 23.50% 22.71% 26.93% 64.67% 25.47% 14.32% 22.51% 23.54% 27.56% 28.91% 21.76%
Cash Return on Invested Capital (CROIC)		 9.92% 11.91% 25.25% 21.76% 21.68% 19.31% 7.86% 11.17% 12.49% 13.95% 13.80%
Operating Return on Assets (OROA)		 8.87% 8.05% 10.13% 27.70% 10.12% 6.32% 9.05% 9.63% 10.79% 10.48% 8.87%
Return on Assets (ROA)		 5.46% 5.20% 6.41% 18.80% 6.67% 3.08% 5.40% 5.95% 7.24% 7.55% 5.20%
Return on Common Equity (ROCE)		 23.36% 22.57% 26.85% 64.49% 25.40% 14.28% 22.51% 23.54% 27.56% 28.91% 21.76%
Return on Equity Simple (ROE_SIMPLE)		 16.13% 0.00% 19.33% 27.13% 28.06% 0.00% 25.92% 17.85% 18.80% 0.00% 23.46%
Net Operating Profit after Tax (NOPAT)		 106 104 125 267 117 64 106 109 135 126 96
NOPAT Margin		 5.57% 5.29% 6.17% 14.96% 6.16% 3.70% 5.75% 5.97% 6.81% 6.88% 5.10%
Net Nonoperating Expense Percent (NNEP)		 1.12% 1.25% 1.28% 0.93% 1.11% 1.18% 1.51% 1.36% 1.41% 1.36% 1.30%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.55% - - - 1.65% 2.76% - - 3.33% 2.53%
Cost of Revenue to Revenue		 88.42% 88.72% 88.41% 87.89% 87.92% 88.95% 88.47% 88.45% 88.01% 87.38% 88.87%
SG&A Expenses to Revenue		 4.56% 5.18% 4.14% 4.93% 4.59% 6.56% 4.60% 4.24% 4.20% 5.11% 4.74%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 4.61% 5.28% 3.85% -8.18% 4.54% 6.51% 4.44% 4.18% 3.90% 5.11% 4.69%
Earnings before Interest and Taxes (EBIT)		 130 116 155 364 141 80 129 131 158 136 116
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 163 155 191 400 175 116 164 165 193 172 152
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.43 3.27 3.19 3.50 3.18 3.72 3.82 3.88 4.44 3.36 3.74
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.77 0.72 0.70 0.84 0.76 0.89 0.92 0.86 0.97 0.71 0.75
Price to Earnings (P/E)		 21.47 18.49 16.60 12.93 11.34 13.91 14.72 21.73 23.64 14.62 15.95
Dividend Yield		 1.41% 1.46% 1.49% 1.23% 1.35% 1.16% 1.14% 1.20% 1.02% 1.37% 1.25%
Earnings Yield		 4.66% 5.41% 6.02% 7.73% 8.82% 7.19% 6.79% 4.60% 4.23% 6.84% 6.27%
Enterprise Value to Invested Capital (EV/IC)		 2.02 1.97 2.08 2.22 2.05 2.28 2.31 2.25 2.49 1.99 2.10
Enterprise Value to Revenue (EV/Rev)		 1.08 1.02 0.95 1.09 1.01 1.16 1.20 1.15 1.26 1.00 1.05
Enterprise Value to EBITDA (EV/EBITDA)		 13.20 12.03 10.84 9.18 8.42 9.80 10.23 13.58 14.54 10.74 11.53
Enterprise Value to EBIT (EV/EBIT)		 17.62 15.87 13.97 10.95 10.00 11.68 12.25 17.51 18.63 13.46 14.54
Enterprise Value to NOPAT (EV/NOPAT)		 22.10 19.32 16.99 13.99 12.74 15.16 15.88 21.29 22.42 15.66 16.88
Enterprise Value to Operating Cash Flow (EV/OCF)		 16.54 14.70 14.81 16.59 16.23 21.82 21.23 21.05 20.99 15.09 15.86
Enterprise Value to Free Cash Flow (EV/FCFF)		 20.27 16.40 7.67 9.90 9.18 11.54 30.39 20.07 19.79 14.20 15.13
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.40 1.39 1.40 1.24 1.24 1.18 1.18 1.33 1.34 1.41 1.52
Long-Term Debt to Equity		 1.39 1.38 1.38 1.20 1.20 1.13 1.13 1.21 1.20 1.21 1.25
Financial Leverage		 1.41 1.40 1.27 1.23 1.21 1.22 1.12 1.17 1.18 1.24 1.31
Leverage Ratio		 3.46 3.39 3.49 3.24 3.20 3.11 3.25 3.15 3.18 3.14 3.21
Compound Leverage Factor		 2.66 2.48 2.77 2.98 2.59 1.87 2.39 2.40 2.53 2.47 2.38
Debt to Total Capital		 58.32% 58.21% 58.40% 55.27% 55.32% 54.04% 54.22% 57.15% 57.25% 58.47% 60.25%
Short-Term Debt to Total Capital		 0.37% 0.76% 1.13% 1.50% 1.69% 1.98% 2.34% 5.20% 5.83% 8.24% 10.70%
Long-Term Debt to Total Capital		 57.95% 57.45% 57.27% 53.76% 53.63% 52.06% 51.87% 51.95% 51.42% 50.22% 49.55%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.25% 0.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 41.44% 41.54% 41.60% 44.73% 44.68% 45.96% 45.78% 42.85% 42.75% 41.53% 39.75%
Debt to EBITDA		 3.86 3.65 3.50 2.49 2.46 2.38 2.44 3.50 3.38 3.20 3.34
Net Debt to EBITDA		 3.78 3.48 2.88 2.11 2.12 2.27 2.38 3.42 3.31 3.12 3.28
Long-Term Debt to EBITDA		 3.84 3.60 3.44 2.43 2.38 2.29 2.33 3.18 3.04 2.75 2.75
Debt to NOPAT		 6.47 5.86 5.49 3.80 3.72 3.68 3.78 5.48 5.22 4.66 4.90
Net Debt to NOPAT		 6.32 5.60 4.52 3.22 3.21 3.52 3.69 5.36 5.11 4.54 4.80
Long-Term Debt to NOPAT		 6.43 5.79 5.39 3.70 3.60 3.55 3.62 4.98 4.69 4.00 4.03
Altman Z-Score		 2.54 2.60 2.43 2.95 2.73 2.95 3.00 2.89 3.06 2.74 2.75
Noncontrolling Interest Sharing Ratio		 0.60% 0.60% 0.30% 0.29% 0.28% 0.29% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.01 1.06 1.08 1.14 1.13 0.98 0.95 0.85 0.87 0.83 0.78
Quick Ratio		 0.90 0.93 0.91 1.08 1.08 0.87 0.85 0.77 0.80 0.76 0.72
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 139 176 650 515 353 243 -157 133 190 175 150
Operating Cash Flow to CapEx		 2,133.33% 2,071.43% 1,366.67% 2,500.00% 2,525.00% 572.73% 1,633.33% 2,300.00% 1,588.89% 766.67% 1,250.00%
Free Cash Flow to Firm to Interest Expense		 4.65 5.68 20.32 17.76 13.06 7.60 -4.61 4.28 5.93 6.05 4.99
Operating Cash Flow to Interest Expense		 4.27 4.68 2.56 5.17 3.74 1.97 2.88 4.45 4.47 3.97 3.33
Operating Cash Flow Less CapEx to Interest Expense		 4.07 4.45 2.38 4.97 3.59 1.63 2.71 4.26 4.19 3.45 3.07
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.30 1.36 1.33 1.36 1.36 1.37 1.30 1.34 1.35 1.42 1.44
Accounts Receivable Turnover		 6.94 7.90 7.37 7.71 7.42 8.05 7.53 7.66 7.26 7.82 7.73
Inventory Turnover		 0.00 100.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 75.94 80.25 82.30 83.12 83.42 81.36 78.95 78.89 78.49 76.71 77.02
Accounts Payable Turnover		 7.85 11.03 8.40 8.12 8.17 11.04 8.80 8.85 8.40 11.00 10.06
Days Sales Outstanding (DSO)		 52.58 46.22 49.52 47.33 49.20 45.36 48.47 47.62 50.26 46.70 47.22
Days Inventory Outstanding (DIO)		 0.00 3.61 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 46.51 33.09 43.47 44.93 44.70 33.07 41.46 41.26 43.46 33.19 36.27
Cash Conversion Cycle (CCC)		 6.07 16.74 6.05 2.39 4.50 12.28 7.01 6.36 6.81 13.51 10.95
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,016 3,969 3,530 3,768 3,780 3,790 3,793 3,744 3,725 3,741 3,739
Invested Capital Turnover		 1.86 1.92 2.04 1.98 1.97 1.92 1.98 1.94 1.97 1.99 1.99
Increase / (Decrease) in Invested Capital		 -33 -72 -525 -248 -236 -179 263 -24 -55 -49 -54
Enterprise Value (EV)		 8,107 7,822 7,347 8,379 7,757 8,642 8,745 8,422 9,277 7,457 7,866
Market Capitalization		 5,777 5,547 5,394 6,454 5,805 6,637 6,711 6,303 7,164 5,293 5,632
Book Value per Share		 $30.58 $31.01 $31.22 $34.33 $34.53 $34.29 $34.06 $31.72 $32.55 $32.26 $31.53
Tangible Book Value per Share		 ($41.09) ($40.75) ($39.46) ($36.49) ($36.76) ($37.65) ($37.89) ($40.25) ($41.32) ($42.00) ($43.91)
Total Capital		 4,069 4,078 4,067 4,120 4,091 3,884 3,842 3,792 3,771 3,797 3,786
Total Debt		 2,373 2,374 2,375 2,277 2,263 2,099 2,083 2,167 2,159 2,220 2,281
Total Long-Term Debt		 2,358 2,343 2,329 2,215 2,194 2,022 1,993 1,970 1,939 1,907 1,876
Net Debt		 2,320 2,265 1,953 1,925 1,952 2,005 2,034 2,119 2,113 2,164 2,234
Capital Expenditures (CapEx)		 6.00 7.00 6.00 6.00 4.00 11 6.00 6.00 9.00 15 8.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -21 -7.00 -254 -118 -80 -44 -22 -40 -3.00 15 32
Debt-free Net Working Capital (DFNWC)		 32 102 168 234 231 50 27 8.00 43 71 79
Net Working Capital (NWC)		 17 71 122 172 162 -27 -63 -189 -177 -242 -326
Net Nonoperating Expense (NNE)		 26 29 27 20 24 25 29 28 29 28 28
Net Nonoperating Obligations (NNO)		 2,320 2,265 1,838 1,925 1,952 2,005 2,034 2,119 2,113 2,164 2,234
Total Depreciation and Amortization (D&A)		 33 39 36 36 34 36 35 34 35 36 36
Debt-free, Cash-free Net Working Capital to Revenue		 -0.28% -0.09% -3.28% -1.53% -1.04% -0.59% -0.30% -0.55% -0.04% 0.20% 0.43%
Debt-free Net Working Capital to Revenue		 0.43% 1.32% 2.17% 3.04% 3.01% 0.67% 0.37% 0.11% 0.58% 0.95% 1.05%
Net Working Capital to Revenue		 0.23% 0.92% 1.58% 2.24% 2.11% -0.36% -0.87% -2.59% -2.40% -3.24% -4.34%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.45 $1.36 $1.80 $4.60 $1.79 $0.79 $1.49 $1.59 $2.15 $2.00 $1.43
Adjusted Weighted Average Basic Shares Outstanding		 54.63M 54.20M 53.68M 52.94M 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M
Adjusted Diluted Earnings per Share		 $1.45 $1.34 $1.79 $4.56 $1.76 $0.77 $1.48 $1.58 $2.13 $1.98 $1.42
Adjusted Weighted Average Diluted Shares Outstanding		 54.63M 54.20M 53.68M 52.94M 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 54.63M 54.20M 53.68M 52.94M 52.06M 51.65M 51.23M 49.52M 48.88M 47.74M 46.87M
Normalized Net Operating Profit after Tax (NOPAT)		 107 104 120 94 117 64 106 109 135 126 96
Normalized NOPAT Margin		 5.62% 5.29% 5.93% 5.29% 6.16% 3.70% 5.75% 5.97% 6.81% 6.88% 5.10%
Pre Tax Income Margin		 5.24% 4.32% 6.07% 18.78% 6.02% 2.76% 5.14% 5.50% 6.38% 5.82% 4.58%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.33 3.74 4.84 12.55 5.22 2.50 3.79 4.23 4.94 4.69 3.87
NOPAT to Interest Expense		 3.55 3.36 3.91 9.20 4.32 2.01 3.12 3.50 4.21 4.36 3.19
EBIT Less CapEx to Interest Expense		 4.13 3.52 4.66 12.34 5.07 2.16 3.62 4.03 4.66 4.17 3.60
NOPAT Less CapEx to Interest Expense		 3.35 3.13 3.72 9.00 4.17 1.66 2.95 3.31 3.93 3.84 2.92
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 31.99% 27.39% 25.69% 16.60% 15.79% 16.56% 17.11% 26.55% 25.08% 20.72% 20.96%
Augmented Payout Ratio		 134.93% 115.51% 108.56% 78.40% 84.41% 96.65% 104.17% 197.59% 194.72% 174.86% 190.09%

Key Financial Trends

Science Applications International (SAIC) reported Q1 2026 results that show continued free cash flow generation and solid operating cash flow, but signs of slowing revenue growth, margin pressure and higher leverage compared with prior years.

  • Free Cash Flow to Firm (FCFF) turned positive at $149.7 million in Q1 2026, compared with a negative $156.8 million in Q1 2025.
  • Net Cash from Operating Activities was $100 million in Q1 2026, up from $98 million in Q1 2025 and $84 million in Q1 2024.
  • Asset Turnover improved to 1.44× in Q1 2026 from 1.30× in Q1 2025, indicating more efficient use of assets.
  • Dividend yield remains modest at 1.25% in Q1 2026, broadly in line with historical levels around 1.1–1.4%.
  • Valuation multiples (P/E ~16×, EV/EBITDA ~11.5×) are roughly in line with the company’s long‐term trading range.
  • Revenue growth decelerated to 1.62% year‐over‐year in Q1 2026, down from 6.32% in Q1 2025 and 6.28% in Q1 2024.
  • Net Operating Profit after Tax (NOPAT) margin contracted to 5.10% in Q1 2026 from 5.75% in Q1 2025 and 5.75% in Q1 2024.
  • Return on Invested Capital (ROIC) fell to 10.16% in Q1 2026, down from 11.40% in Q1 2025 and 12.58% in Q1 2024.
  • Debt‐to‐Total Capital rose to 60.25% in Q1 2026 from 58.42% in Q1 2025 and 54.22% in Q1 2024, reflecting higher leverage.
  • Net Debt/EBITDA increased to 3.28× in Q1 2026, versus 2.38× in Q1 2025 and 2.38× in Q1 2024.
07/16/25 07:00 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Science Applications International's Financials

When does Science Applications International's fiscal year end?

According to the most recent income statement we have on file, Science Applications International's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

How has Science Applications International's net income changed over the last 10 years?

Science Applications International's net income appears to be on an upward trend, with a most recent value of $362 million in 2025, rising from $141 million in 2015. The previous period was $477 million in 2024.

What is Science Applications International's operating income?
Science Applications International's total operating income in 2025 was $563 million, based on the following breakdown:
  • Total Gross Profit: $892 million
  • Total Operating Expenses: $329 million
How has Science Applications International's revenue changed over the last 10 years?

Over the last 10 years, Science Applications International's total revenue changed from $3.89 billion in 2015 to $7.48 billion in 2025, a change of 92.5%.

How much debt does Science Applications International have?

Science Applications International's total liabilities were at $3.67 billion at the end of 2025, a 4.0% increase from 2024, and a 251.4% increase since 2015.

How much cash does Science Applications International have?

In the past 10 years, Science Applications International's cash and equivalents has ranged from $0.00 in 2018 to $301 million in 2015, and is currently $56 million as of their latest financial filing in 2025.

How has Science Applications International's book value per share changed over the last 10 years?

Over the last 10 years, Science Applications International's book value per share changed from 7.55 in 2015 to 32.26 in 2025, a change of 327.2%.


Related Companies

This page (NASDAQ:SAIC) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...
Crypto Swap Profits | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Is this secretive Asian company trying to take over Bitcoin?
A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...
Brownstone Research | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored